The FDA announced on 2023-11-29 that Randox Laboratories Ltd. is recalling RX Series Copper (Cu) Assay Ref. Number CU2340 due to the risk of falsely elevated copper results. The agency stated that running the assay directly after Total Protein can cause this error.
How to tell if you have it
- Brand: Randox
- Product: RX Series Copper (Cu) Assay
- Ref. Number: CU2340
- Catalogue Number/GTIN: CU2340 05055273201949
- Lot codes: 592278, 610661, 610669, 629021, 647201, 657944
- Quantity: 3,053 kits (2 US, 3,051 OUS)
- Distribution: SC and OK
The hazard
Randox Laboratories released an update to the Carryover Avoidance Technical Bulletin detailing that Copper should not be run directly after Total Protein on RX series instruments. If the copper assay is run after total protein, it could lead to falsely elevated copper results.
Context
GovInfoNow's records show Randox Laboratories Ltd. has 49 other recalls on record since 2017-06-07. Other recent recalls of similar products include Randox Cystatin C Reagent Recall (2024-06-07), Randox Evidence MultiSTAT Software v3.7 Recall (2024-04-05), and Randox Clinical Chemistry Calibration Serum Recall (2024-03-05). Siemens Atellica CH RCRP Test May Give False High Results was recalled on 2026-08-17.